Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06IGT
|
||||
Former ID |
DNC003756
|
||||
Drug Name |
(3S,4R)-3-Benzyl-7-isopropyl-chroman-4-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H22O2
|
||||
Canonical SMILES |
CC(C)C1=CC2=C(C=C1)C(C(CO2)CC3=CC=CC=C3)O
|
||||
InChI |
1S/C19H22O2/c1-13(2)15-8-9-17-18(11-15)21-12-16(19(17)20)10-14-6-4-3-5-7-14/h3-9,11,13,16,19-20H,10,12H2,1-2H3/t16-,19+/m0/s1
|
||||
InChIKey |
OJNGOFXPXHHONH-QFBILLFUSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Leukotriene B4 receptor 1 | Target Info | Inhibitor | [1] | |
Leukotriene B4 receptor 2 | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Neuroactive ligand-receptor interactionhsa04020:Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | ||||
Reactome | Leukotriene receptors | ||||
G alpha (q) signalling eventsR-HSA-391906:Leukotriene receptors | |||||
G alpha (q) signalling events | |||||
WikiPathways | Nucleotide GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Spinal Cord Injury | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP2664:Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | 3-Substituted-4-hydroxy-7-chromanylacetic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor, Bioorg. Med. Chem. Lett. 7(17):2307-2312 (1997). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.